U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

The 35th Annual IFTSA and Mars Product Development Competition is a chance for students to take the skills and knowledge learned in school and apply them to a real-world situation. Each participating ...

We will work with stakeholders to champion pharmacy and pharmaceutical sciences to benefit patients ... exceptional students and an outstanding reputation. This strategic plan will enable us to ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

In a statement to CNN, Merck said, “An overwhelming body of scientific evidence, including more than 30 years of research and development along with real world evidence generated by Merck and by ...

However, while the new templates establish standards, they may still be too general and not fully adapted to the increasingly sophisticated protocols and techniques employed by the pharmaceutical ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.

The South Downs Local Plan is being reviewed to ensure it is ... "Planning is the beating heart of the national park, deciding where development takes place and how we conserve and enhance its ...

The subsidy plan is expected to stimulate market consumption and increase sales in the digital product sector ... program is expected to create more development opportunities for the relevant ...

Germany’s pharmaceutical sector is taking steps to combat worsening drug supply shortages, which have been driven by production bottlenecks, global dependencies, and increasing demand. In recent ...

The U.S. Department of Health and Human Services (HHS) said in a press release that the funding will allow the pharmaceutical company to accelerate the development of an H5N1 mRNA influenza ...